BR9608716A - Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina - Google Patents

Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina

Info

Publication number
BR9608716A
BR9608716A BR9608716A BR9608716A BR9608716A BR 9608716 A BR9608716 A BR 9608716A BR 9608716 A BR9608716 A BR 9608716A BR 9608716 A BR9608716 A BR 9608716A BR 9608716 A BR9608716 A BR 9608716A
Authority
BR
Brazil
Prior art keywords
immunodeficiency virus
feline immunodeficiency
vaccine against
genetically altered
effective vaccine
Prior art date
Application number
BR9608716A
Other languages
English (en)
Inventor
Lloyd George Chavez Jr
Terri Wasmoen
Chenglin Huang
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9608716A publication Critical patent/BR9608716A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BR9608716A 1995-06-07 1996-06-03 Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina BR9608716A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/479,703 US6300118B1 (en) 1995-06-07 1995-06-07 Plasmids comprising a genetically altered feline immunodeficiency virus genome
PCT/US1996/008639 WO1996040953A1 (en) 1995-06-07 1996-06-03 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection

Publications (1)

Publication Number Publication Date
BR9608716A true BR9608716A (pt) 1999-06-29

Family

ID=23905072

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608716A BR9608716A (pt) 1995-06-07 1996-06-03 Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina

Country Status (10)

Country Link
US (1) US6300118B1 (pt)
EP (1) EP0832265A1 (pt)
JP (1) JPH11507515A (pt)
AU (1) AU719034B2 (pt)
BR (1) BR9608716A (pt)
CA (1) CA2223969A1 (pt)
CO (1) CO4480038A1 (pt)
NZ (1) NZ310055A (pt)
WO (1) WO1996040953A1 (pt)
ZA (1) ZA964679B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2356200B (en) * 1997-12-22 2002-05-01 Oxford Biomedica Ltd Retroviral vectors
PT1895010E (pt) * 1997-12-22 2012-01-25 Oxford Biomedica Ltd Vectores com base no vírus da anemia infecciosa equina (eiav)
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
US6764676B1 (en) 1998-08-24 2004-07-20 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
EP1074625A3 (en) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7201903B2 (en) * 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011919A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1697534B1 (en) 2003-12-01 2010-06-02 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US7285272B2 (en) * 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
DE602005027326D1 (de) * 2004-02-19 2011-05-19 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
WO2006011917A1 (en) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7335360B2 (en) * 2004-06-30 2008-02-26 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5256767A (en) 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
ATE208813T1 (de) 1988-02-16 2001-11-15 Greatbatch Gen Aid Ltd Modifizierte zellen mit resistenz gegen retroviralinfektionen
US5324664A (en) 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
US5674720A (en) * 1988-11-10 1997-10-07 United States Of America Design and construction of non-infectious human retroviral mutants deficient in genomic RNA
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
WO1990013573A1 (en) 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus
US5252348A (en) 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
WO1993001278A1 (en) 1991-07-05 1993-01-21 The Regents Of The University Of California Feline lymphoid cell lines capable of producing fiv
US5413927A (en) 1991-09-03 1995-05-09 North Carolina State University Feline immunodeficiency virus isolate NCSU1Lb
AU2800392A (en) 1991-10-28 1993-06-07 Institut Pasteur Induction of protection against viral infection by synergy between viral proteins and viral peptides
PT584348E (pt) 1992-03-11 2005-10-31 Powderject Vaccines Inc Vacina genetica para virus da imunodeficiencia
DK0576092T3 (da) 1992-06-26 2003-02-17 Akzo Nobel Nv Rekombineret felin herbesvirusvaccine
GB9215233D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0662139A1 (en) 1992-09-21 1995-07-12 Chiron Corporation Recombinant retroviral vector against felv and/or fiv
WO1994020622A1 (en) 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus

Also Published As

Publication number Publication date
CO4480038A1 (es) 1997-07-09
NZ310055A (en) 1999-06-29
US6300118B1 (en) 2001-10-09
AU719034B2 (en) 2000-05-04
JPH11507515A (ja) 1999-07-06
WO1996040953A1 (en) 1996-12-19
CA2223969A1 (en) 1996-12-19
EP0832265A1 (en) 1998-04-01
AU6037296A (en) 1996-12-30
ZA964679B (en) 1997-12-05

Similar Documents

Publication Publication Date Title
BR9609089A (pt) Vírus raccoon pox recombinantes e seu uso como vacina eficaz contra infecção por vírus da imunodeficiéncia felina
BR9608716A (pt) Vírus da imunodeficiência felina alterado geneticamente e seu uso como vacina eficaz contra infecção por vírus da imunodeficiência felina
BR9609258A (pt) Vacinas contra hepatite c
BR8705535A (pt) Polipeptideos derivados do gene de tegumento de virus de imunodeficiencia humana em celulas de insetos infectados por baculovirus
EE9900436A (et) Inimese immuunpuudulikkuse viiruse ja teiste nakkushaiguste mikroobivastane tõkestamine ja käitlemine
ZA964680B (en) Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.
BR9603058A (pt) Dispositivo de proteção contra sobretens es e aparelho de proteção contra sobretensão de voltagem
MX9101810A (es) Vacuna contra virus de anemia de polio y diagnostico
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
MX9301136A (es) Composiciones que contienen psyllium.
NO955305D0 (no) Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
FI965196A0 (fi) HIV-infektion yhdistelmähoito
BR9305933A (pt) Antigenos protetores contra infecção de echinococcus granulosus e vacinas contendo tais antigenos
ATE103496T1 (de) Impfstoff fuer den schutz von katzen gegen infektioese katzenperitonitis.
BR9611895A (pt) Derivados de 5-naftalen-1,3-dioxano preparação e uso terapêutico dos mesmos
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
NO922715D0 (no) Optisk aktive isoindolin-derivater, deres fremstilling oganvendelse
DK0396193T3 (da) Hundekoronavirusvaccine
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas
NO971003D0 (no) Enteral vaksine mot vaginale infeksjoner
AU7276198A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
AU6268199A (en) Live virus vaccines to protect primates from hiv-1 infection and disease
KR970705544A (ko) N-페닐테트라히드로인다졸, 그의 제조 및 작물 보호제로서의 그의 용도(N-Phenyltetrahydroindazoles, Their Preparation, and Their Use as Crop Protection Agents)
BR9205290A (pt) Vacine e metodo de tratamento de infeccao do virus de imunodeficiencia humana

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: IMDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.